Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jaime Branco

Showing results (71-80 of 75) with videos related to

Pageof 8
Sort By:
You have reached the last page of results.This site can display upto 75 results.
Acta Reumatologica Portuguesa|November 11, 2006
[Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience]João Eurico Fonseca, Helena Canhão, Cândida Silva, et al.
Biomed Research International|April 3, 2015
TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapyHelena Canhão, Ana Maria Rodrigues, Maria José Santos, et al.
Arthritis Research & Therapy|April 6, 2007
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoterJoão Eurico Fonseca, João Cavaleiro, José Teles, et al.
Acta Reumatologica Portuguesa|May 28, 2010
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - March 2010 updateJoão Eurico Fonseca, Helena Canhão, Paulo Reis, et al.
Acta Reumatologica Portuguesa|April 5, 2012
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 updateJoão Eurico Fonseca, Miguel Bernardes, Helena Canhão, et al.
Pageof 8

Showing results (71-80 of 75) with videos related to

Sort By:
Pageof 8
You have reached the last page of results.This site can display upto 75 results.
Acta Reumatologica Portuguesa|November 11, 2006
[Tuberculosis in rheumatic patients treated with tumour necrosis factor alpha antagonists: the Portuguese experience]João Eurico Fonseca, Helena Canhão, Cândida Silva, et al.
Biomed Research International|April 3, 2015
TRAF1/C5 but not PTPRC variants are potential predictors of rheumatoid arthritis response to anti-tumor necrosis factor therapyHelena Canhão, Ana Maria Rodrigues, Maria José Santos, et al.
Arthritis Research & Therapy|April 6, 2007
Contribution for new genetic markers of rheumatoid arthritis activity and severity: sequencing of the tumor necrosis factor-alpha gene promoterJoão Eurico Fonseca, João Cavaleiro, José Teles, et al.
Acta Reumatologica Portuguesa|May 28, 2010
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - March 2010 updateJoão Eurico Fonseca, Helena Canhão, Paulo Reis, et al.
Acta Reumatologica Portuguesa|April 5, 2012
Portuguese guidelines for the use of biological agents in rheumatoid arthritis - October 2011 updateJoão Eurico Fonseca, Miguel Bernardes, Helena Canhão, et al.
Pageof 8